Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Sunitinib with Salvage Radiation for Recurrent Prostate Cancer
NCT00734851Phase 2Terminated
- Sponsor
- Duke University
- Start
- Dec 2008
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in prostate cancer (PCa), sponsored by Duke University. Started Dec 2008; status: terminated.
02
Drugs
sunitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00734851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734851.